Concepedia

M. Shiffman

MS

Statistics

Publications

22

Citations

1.1K

H-Index

17

Active since

1991

Affiliations

Virginia Commonwealth University Medical Center(Current)

Duke University

University of North Carolina at Chapel Hill

Bach & Godofsky Infectious Diseases

M. Shiffman is an author at Virginia Commonwealth University Medical Center specializing in antiviral therapy, pharmacy, and viral hepatitis.

Publications per year

1991–2017

22

Publications

22

Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity.

M. Shiffman, H J Sugerman, J. M. Kellum et al. · PubMed · 1991 · 367 citations

Medicine, Surgery, Gastroenterology +12

Living donor liver transplantation: Summary of a conference at The National Institutes of Health

M. Shiffman · Liver Transplantation · 2002 · 143 citations · Full text

Medicine, Surgery, Hepatology +13

A randomized double-blind, placebo-controlled trial ursodeoxycholic acid in primary biliary cirrhosis

Burton Combes, Robert L. Carithers, Willis C. Maddrey et al. · European Journal of Gastroenterology & Hepatology · 1995 · 72 citations

Medicine, Internal Medicine, Pharmacology +10

991 FINAL RESULTS OF THE IDEAL (INDIVIDUALIZED DOSING EFFICACY VERSUS FLAT DOSING TO ASSESS OPTIMAL PEGYLATED INTERFERON THERAPY) PHASE IIIB STUDY

Mark Sulkowski, E. Läwitz, M. Shiffman et al. · Journal of Hepatology · 2008 · 47 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +10

1360 PEGYLATED INTERFERON-LAMBDA (PEGIFN-λ) SHOWS SUPERIOR VIRAL RESPONSE WITH IMPROVED SAFETY AND TOLERABILITY VERSUS PEGIFNα-2A IN HCV PATIENTS (Gl/2/3/4): EMERGE PHASE IIB THROUGH WEEK 12

Stefan Zeuzem, S. Arora, B. Bacon et al. · Journal of Hepatology · 2011 · 46 citations

Pharmacy, Infectious Diseases, Hepatitis Pharmacotherapy +11

1–5 of 22